avacincaptad pegol sodium

It is formulated by 1 pharmaceutical company such as ASTELLAS. It is marketed under 1 brand name, including IZERVAY. Available in 1 different strength, such as EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML), and administered through 1 route including SOLUTION;INTRAVITREAL.

Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...

watch_later Watch: autorenew Loading watch analysis...

rocket_launch Opportunity: autorenew Loading opportunity analysis...

Country

flag

Legal Status

gavel

Expiry From

calendar_today

Expiry To

calendar_today

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength	Route of Administration	Companies	Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

	Patent Number	Publication Date	Legal Status	Patent Expiry Date
{"application_id":"113742","ingredient":"AVACINCAPTAD PEGOL SODIUM","trade_name":"IZERVAY","family_id":"593667596ccf4e708205","publication_number":"US10947544B2","cleaned_patent_number":"10947544","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-02-14","publication_date":"2021-03-16","legal_status":"Expired"}	US10947544B2 Molecular	16 Mar, 2021	Expired	14 Feb, 2025
{"application_id":"113735","ingredient":"AVACINCAPTAD PEGOL SODIUM","trade_name":"IZERVAY","family_id":"593667596ccf4e708205","publication_number":"US7538211B2","cleaned_patent_number":"7538211","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-02-14","publication_date":"2009-05-26","legal_status":"Granted"}	US7538211B2 Molecular	26 May, 2009	Granted	14 Feb, 2025
{"application_id":"113737","ingredient":"AVACINCAPTAD PEGOL SODIUM","trade_name":"IZERVAY","family_id":"593667596ccf4e708205","publication_number":"US7803931B2","cleaned_patent_number":"7803931","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-02-14","publication_date":"2010-09-28","legal_status":"Granted"}	US7803931B2 Molecular	28 Sep, 2010	Granted	14 Feb, 2025
{"application_id":"113736","ingredient":"AVACINCAPTAD PEGOL SODIUM","trade_name":"IZERVAY","family_id":"593667596ccf4e708205","publication_number":"US7579456B2","cleaned_patent_number":"7579456","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-02-14","publication_date":"2009-08-25","legal_status":"Granted"}	US7579456B2 Molecular	25 Aug, 2009	Granted	14 Feb, 2026
{"application_id":"113741","ingredient":"AVACINCAPTAD PEGOL SODIUM","trade_name":"IZERVAY","family_id":"593667596ccf4e708205","publication_number":"US9617546B2","cleaned_patent_number":"9617546","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-02-14","publication_date":"2017-04-11","legal_status":"Granted"}	US9617546B2 Molecular	11 Apr, 2017	Granted	14 Feb, 2026
{"application_id":"113738","ingredient":"AVACINCAPTAD PEGOL SODIUM","trade_name":"IZERVAY","family_id":"593667596ccf4e708205","publication_number":"US8236773B2","cleaned_patent_number":"8236773","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-11-11","publication_date":"2012-08-07","legal_status":"Granted"}	US8236773B2	07 Aug, 2012	Granted	11 Nov, 2026
{"application_id":"130706","ingredient":"AVACINCAPTAD PEGOL SODIUM","trade_name":"IZERVAY","family_id":"78b4a951969f4feab725","publication_number":"US12016875B2","cleaned_patent_number":"12016875","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-07-11","publication_date":"2024-06-25","legal_status":"Granted"}	US12016875B2	25 Jun, 2024	Granted	11 Jul, 2034
{"application_id":"30751","ingredient":"AVACINCAPTAD PEGOL SODIUM","trade_name":"IZERVAY","family_id":"78b4a951969f4feab725","publication_number":"US11273171B2","cleaned_patent_number":"11273171","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-07-11","publication_date":"2022-03-15","legal_status":"Granted"}	US11273171B2	15 Mar, 2022	Granted	11 Jul, 2034
{"application_id":"34186","ingredient":"AVACINCAPTAD PEGOL SODIUM","trade_name":"IZERVAY","family_id":"78b4a951969f4feab725","publication_number":"US11491176B2","cleaned_patent_number":"11491176","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-07-11","publication_date":"2022-11-08","legal_status":"Granted"}	US11491176B2	08 Nov, 2022	Granted	11 Jul, 2034

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID	Title	Status	Phase	Conditions	Start Date	Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

Filter by Country

No suppliers found.

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.